title: Prognostic markers in patients who have recovered from an acute variceal bleeding: role of HVPG measurement.
authors: Liver and Transplant Unit, Instituto de Investigación Sanitaria Gregorio Marañón, Ciberehd, Madrid, Spain. rbanares@telefonica.net
authors: Rafael
authors: R
authors: Bañares
authors: María-Vega
authors: MV
authors: Catalina
authors: Cristina
authors: C
authors: Ripoll
authors: Diego
authors: D
authors: Rincón
mesh_terms: D000319:Adrenergic beta-Antagonists / Q000008:administration & dosage / Q000627:therapeutic use; D000959:Antihypertensive Agents / Q000008:administration & dosage / Q000627:therapeutic use; D015415:Biomarkers / Q000032:analysis; D004932:Esophageal and Gastric Varices / Q000150:complications / Q000175:diagnosis* / Q000188:drug therapy / Q000401:mortality / Q000503:physiopathology / Q000517:prevention & control; D006471:Gastrointestinal Hemorrhage / Q000150:complications / Q000175:diagnosis* / Q000188:drug therapy / Q000401:mortality / Q000503:physiopathology; D006490:Hemostatics / Q000008:administration & dosage / Q000627:therapeutic use; D006801:Humans; D006975:Hypertension, Portal / Q000150:complications / Q000175:diagnosis* / Q000188:drug therapy / Q000401:mortality / Q000503:physiopathology; D008099:Liver / Q000473:pathology* / Q000503:physiopathology; D008103:Liver Cirrhosis / Q000150:complications / Q000175:diagnosis* / Q000503:physiopathology; D017082:Portal Pressure; D019168:Portasystemic Shunt, Transjugular Intrahepatic / Q000379:methods; D011379:Prognosis; D011433:Propranolol / Q000008:administration & dosage / Q000627:therapeutic use; D016032:Randomized Controlled Trials as Topic; D016019:Survival Analysis
chemical_list: D000319:Adrenergic beta-Antagonists; D000959:Antihypertensive Agents; D015415:Biomarkers; D006490:Hemostatics; D011433:Propranolol